Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / ADS
Total 13F shares
6,062,678
Share change
+117,088
Total reported value
$121,556,000
Put/Call ratio
243%
Price per share
$20.05
Number of holders
31
Value change
-$455,619
Number of buys
17
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q3 2021

As of 30 Sep 2021, Renalytix plc - ADS (RNLXY) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,062,678 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Parian Global Management LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FRED ALGER MANAGEMENT, LLC, ArrowMark Colorado Holdings LLC, PINNACLE ASSOCIATES LTD, FIL Ltd, GOFEN & GLOSSBERG LLC /IL/, Pentwater Capital Management LP, and LAZARD ASSET MANAGEMENT LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.